Recently oncolytic vaccines [11] and nanoparticles with tumor whole-cell lysate [12] combined with PD-L1 blockade has shown CD8 T cell activation and pre-clinical efficacy in colorectal cancer models. This evidence concerns the gene CD8A and neoplasm.